Your browser is no longer supported. Please, upgrade your browser.
Settings
CBPO China Biologic Products Holdings, Inc. daily Stock Chart
CBPO [NASD]
China Biologic Products Holdings, Inc.
Index- P/E36.14 EPS (ttm)2.06 Insider Own31.45% Shs Outstand36.66M Perf Week-3.49%
Market Cap2.73B Forward P/E15.65 EPS next Y4.77 Insider Trans0.00% Shs Float20.10M Perf Month-9.59%
Income107.40M PEG14.75 EPS next Q1.16 Inst Own48.70% Short Float7.75% Perf Quarter-26.44%
Sales422.60M P/S6.47 EPS this Y2.80% Inst Trans12.80% Short Ratio5.11 Perf Half Y-13.67%
Book/sh33.23 P/B2.24 EPS next Y11.57% ROA6.10% Target Price104.24 Perf Year-9.69%
Cash/sh9.99 P/C7.47 EPS next 5Y2.45% ROE7.90% 52W Range71.85 - 107.44 Perf YTD-5.31%
Dividend- P/FCF39.06 EPS past 5Y18.00% ROI18.70% 52W High-31.83% Beta1.31
Dividend %- Quick Ratio4.30 Sales past 5Y14.90% Gross Margin68.20% 52W Low1.94% ATR2.18
Employees1912 Current Ratio6.20 Sales Q/Q34.80% Oper. Margin- RSI (14)28.36 Volatility3.09% 2.48%
OptionableYes Debt/Eq0.00 EPS Q/Q-21.30% Profit Margin15.90% Rel Volume0.34 Prev Close74.59
ShortableYes LT Debt/Eq0.00 EarningsOct 31 AMC Payout0.00% Avg Volume304.88K Price73.24
Recom1.90 SMA20-7.28% SMA50-15.06% SMA200-15.13% Volume55,116 Change-1.81%
Aug-06-18Downgrade Credit Suisse Outperform → Neutral
May-14-18Downgrade Jefferies Buy → Hold
May-30-17Initiated Goldman Neutral
Mar-01-16Downgrade Credit Suisse Outperform → Neutral
Oct-08-15Initiated Credit Suisse Outperform
Jul-09-15Initiated BofA/Merrill Buy $135
Jul-08-14Reiterated Aegis Capital Buy $50 → $55
Mar-14-14Initiated Oppenheimer Outperform $46
Nov-06-13Downgrade Aegis Capital Buy → Hold
Mar-14-13Reiterated Aegis Capital Buy $22 → $28
May-13-10Reiterated Brean Murray Buy $19 → $20
Mar-26-10Reiterated Brean Murray Buy $15 → $19
Oct-04-18 12:48PM  Investor Criticizes China Biologic Over Rejected Takeover Bid Bloomberg
Sep-26-18 07:50AM  Research Report Identifies The Carlyle Group, China Biologic Products, Ericsson, Dover, GasLog Partners LP, and Spectra Energy Partners, LP with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Sep-24-18 09:44AM  Is China Biologic Products Inc. (CBPO) A Good Stock To Buy? Centurium Capital Thinks So Insider Monkey
Aug-29-18 11:59AM  David Gao Confirms Lawsuit Against China Biologic Products to Protect Shareholders Best Interests Business Wire
Aug-28-18 05:00PM  China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman PR Newswire
Aug-24-18 01:47PM  China Biologic rejects $3.9 bln bid from former CEO Reuters -15.85%
12:35PM  Leading Investor Group Issues Statement Following China Biologics Dilutive Private Placement of Shares Business Wire
11:43AM  [$$] China Biologic Says One Buyout Offer Is Withdrawn, Rejects Another The Wall Street Journal
11:26AM  Here's Why China Biologic Products Stock Dropped Today Motley Fool
10:43AM  BRIEF-PW Medtech Group To Purchase 800,000 China Biologic Products Shares For $80.72 Mln Reuters
08:17AM  China Biologic rejects former CEO-led consortium's offer Reuters
08:00AM  China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement PR Newswire
Aug-21-18 04:05PM  Deals of the day-Mergers and acquisitions Reuters
08:00AM  Today's Research Reports on Trending Tickers: Cronos and China Biologic Products ACCESSWIRE
08:00AM  China Biologic Announces Receipt of Competing Non-Binding Acquisition Proposal PR Newswire
04:46AM  China Biologic gets $3.9 bln offer from former CEO-led consortium Reuters
Aug-20-18 01:52PM  Here's Why China Biologic Products Stock Is Soaring Today Motley Fool +8.71%
01:35PM  China Biologic gets $3.9 billion offer from former CEO-led consortium Reuters
12:26PM  UPDATE 1-China Biologic gets $3.9 bln offer from former CEO-led consortium Reuters
08:38AM  Consortium seeks to acquire China Biologic Products for $3.9 billion in cash MarketWatch
08:30AM  Leading Investor Group Proposes to Acquire China Biologic Products for US$118.00 Per Share in Cash Business Wire
Aug-13-18 08:00AM  China Biologic Names Bing Li as New CEO PR Newswire
Aug-03-18 04:40PM  China Biologic Products: 2Q Earnings Snapshot Associated Press
04:30PM  China Biologic Reports Financial Results for the Second Quarter of 2018 PR Newswire
Jul-27-18 08:00AM  China Biologic Products to Report Second Quarter 2018 Financial Results PR Newswire
Jul-10-18 02:31AM  Ping An Said to Mull Rival Takeover Offer for China Biologic Bloomberg +6.57%
Jul-02-18 08:30AM  China Biologic Announces Results of Its 2018 Annual General Meeting of Shareholders PR Newswire
Jun-22-18 02:47AM  Ex-Warburg Pincus China head targets up to $1.5 bln for China fund - sources Reuters
Jun-19-18 08:10AM  Todays Research Reports on Stocks to Watch: JD.com and China Biologic Products ACCESSWIRE
08:00AM  China Biologic Announces Receipt of Non-Binding Acquisition Proposal PR Newswire
Jun-18-18 05:32PM  WeissLaw LLP Investigates China Biologic Products Holdings, Inc. PR Newswire +21.15%
12:41PM  Here's Why China Biologic Products Holdings Inc. Soared as Much as 25.8% Today Motley Fool
09:42AM  Stocks Slide; Intel Downgraded; JD.com Spikes On Google Deal Investor's Business Daily
07:12AM  CITIC Capital offers to buy China Biologic for $110 per share Reuters
06:52AM  Investment firm CITIC Capital offers to buy China Biologic Products Reuters
Jun-11-18 08:00AM  China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant PR Newswire
Jun-06-18 08:20AM  Analysis: Positioning to Benefit within China Biologic Products, Merus N.V, Adient, G1 Therapeutics, Westport Fuel, and AppFolio Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-31-18 02:58PM  Was China Biologic Products Holdings Incs (NASDAQ:CBPO) Earnings Decline Part Of A Broader Industry Downturn? Simply Wall St.
May-08-18 07:00AM  Blog Exposure - Portola Pharma Receives Approval from FDA for Its Lead Candidate ACCESSWIRE
May-04-18 04:37PM  China Biologic Products: 1Q Earnings Snapshot Associated Press
04:30PM  China Biologic Reports Financial Results for the First Quarter of 2018 PR Newswire
Apr-30-18 11:06AM  Is There An Opportunity With China Biologic Products Holdings Incs (NASDAQ:CBPO) 39% Undervaluation? Simply Wall St.
Apr-27-18 02:34PM  Has China Biologic Products Holdings Inc (NASDAQ:CBPO) Got Enough Cash? Simply Wall St.
Apr-13-18 07:45AM  Investor Expectations to Drive Momentum within Criteo S.A, Prima BioMed, CoStar Group, DBV Technologies S.A, Hollysys Automation Technologies, and China Biologic Products Discovering Underlying Factors of Influence GlobeNewswire
Mar-16-18 08:15AM  Recent Analysis Shows Clementia Pharmaceuticals, MyoKardia, Landec, Sapiens International Corporation N.V, AppFolio, and China Biologic Products Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Feb-28-18 05:00PM  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017 PR Newswire
Feb-23-18 08:00AM  China Biologic Products to Report Fourth Quarter and Fiscal Year 2017 Financial Results PR Newswire
Feb-14-18 08:30AM  China Biologic to Build New Collection Station in Hainan Province PR Newswire
Feb-09-18 12:52PM  Should You Expect China Biologic Products Holdings Inc (NASDAQ:CBPO) To Continue Delivering An ROE Of 20.70%? Simply Wall St.
Jan-08-18 04:32PM  Has China Biologic Products Holdings Inc (NASDAQ:CBPO) Improved Earnings Growth In Recent Times? Simply Wall St.
08:00AM  China Biologic to Attend the 36th Annual J.P. Morgan Healthcare Conference PR Newswire
08:00AM  China Biologic Announces Corporate Update PR Newswire
Jan-03-18 08:06AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
06:00AM  China Biologic Announces Completion of Acquisition of TianXinFu from PWM PR Newswire
Jan-01-18 01:55PM  How Do Analysts See China Biologic Products Holdings Inc (NASDAQ:CBPO) Performing Over The Next Few Years? Simply Wall St.
Dec-29-17 12:52PM  China Biologic Products Holdings, Inc. Value Analysis (NASDAQ:CBPO) : December 29, 2017 Capital Cube
Dec-28-17 07:20AM  China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : December 28, 2017 Capital Cube
Dec-22-17 03:55PM  Should You Be Tempted To Buy China Biologic Products Holdings Inc (NASDAQ:CBPO) Because Of Its PE Ratio? Simply Wall St.
Dec-15-17 08:30AM  China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province PR Newswire
Dec-07-17 02:03PM  Has China Biologic Products Holdings Inc (CBPO) Got Enough Cash To Cover Its Short-Term Obligations? Simply Wall St.
Dec-04-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-22-17 08:20PM  What Do Analysts Think About China Biologic Products Holdings Incs (CBPO) Growth? Simply Wall St.
Nov-21-17 08:08AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-20-17 08:07AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-15-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-14-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-08-17 03:59PM  Calculating The Intrinsic Value Of China Biologic Products Holdings Inc (CBPO) Simply Wall St.
Nov-07-17 09:52AM  ETFs with exposure to China Biologic Products Holdings, Inc. : November 7, 2017 Capital Cube
Nov-02-17 05:47AM  China Biologic Products posts 3Q profit Associated Press
Nov-01-17 04:30PM  China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 PR Newswire
Oct-27-17 10:48AM  ETFs with exposure to China Biologic Products Holdings, Inc. : October 27, 2017 Capital Cube
Oct-26-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Oct-25-17 08:00AM  China Biologic Products to Report Third Quarter of 2017 Financial Results PR Newswire
Oct-13-17 10:36AM  ETFs with exposure to China Biologic Products Holdings, Inc. : October 13, 2017 Capital Cube
08:36AM  China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : October 13, 2017 Capital Cube
08:00AM  China Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition PR Newswire
Oct-12-17 08:30AM  China Biologic Agrees to Acquire TianXinFu from PWM PR Newswire -14.99%
Oct-09-17 08:30AM  China Biologic Receives Approval for Commercial Manufacturing of Human Fibrinogen PR Newswire
Oct-03-17 08:16AM  China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : October 3, 2017 Capital Cube
Sep-28-17 10:10AM  ETFs with exposure to China Biologic Products Holdings, Inc. : September 28, 2017 Capital Cube
Sep-27-17 09:04AM  China Biologic Products Holdings, Inc. :CBPO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 27, 2017 Capital Cube
Sep-12-17 08:07AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Sep-11-17 10:11AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Sep-08-17 10:26AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Sep-01-17 08:02AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-31-17 08:08AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit +7.17%
Aug-30-17 08:03AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-12-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-10-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-09-17 08:05AM  IHS Markit Score upgrades China Biologic Products Holdings Inc to 34 out of 100, despite ranking positively in only one IHS Markit category. Markit
07:00AM  Featured Company News MannKind and One Drop Announce Collaboration to Deliver a Unified Solution for Diabetes Patients ACCESSWIRE
Aug-04-17 02:36AM  China Biologic Products posts 2Q profit Associated Press
Aug-03-17 05:00AM  Investor Network: China Biologic Products, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-17 05:00PM  China Biologic Reports Financial Results for the Second Quarter of 2017 PR Newswire
Jul-25-17 03:44AM  Why China Biologic is the Best of China's Blood Plasma Stocks Barrons.com
Jul-24-17 05:50AM  Edited Transcript of CBPO earnings conference call or presentation 5-Aug-16 11:30am GMT Thomson Reuters StreetEvents
05:50AM  Edited Transcript of CBPO earnings conference call or presentation 24-Feb-17 12:30pm GMT Thomson Reuters StreetEvents
05:49AM  Edited Transcript of CBPO earnings conference call or presentation 7-May-15 11:30am GMT Thomson Reuters StreetEvents
Jul-19-17 08:00AM  China Biologic Products to Report Second Quarter of 2017 Financial Results PR Newswire
Jul-17-17 01:40PM  ETFs with exposure to China Biologic Products, Inc. : July 17, 2017 Capital Cube
China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin for intravenous injection products for original and secondary immunoglobulin deficiency, and auto-immune deficiency diseases; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; human fibrinogen; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing immune globulin intravenous; human antithrombin III; Caprylate/Chromatography Purified and 20 nm virus filtration; human coagulation factor IX; human cytomegalovirus immunoglobulin; and human fibrin sealant products. The company sells its products directly, as well as through distributors. The company was formerly known as China Biologic Products, Inc. and changed its name to China Biologic Products Holdings, Inc. in July 2017. China Biologic Products Holdings, Inc. is headquartered in Beijing, the People's Republic of China.